NP3-742
NP3-742 is an orally active NLRP3 inhibitor that binds to the NLRP3 NACHT domain. NP3-742 inhibits IL-1β release with IC50s of 6 nM and 47 nM in both the cellular and whole blood assays, respectively. NP3-742 is highly selective against a panel of more than 50 enzymes, receptors and sodium and calcium channels. NP3-742 can be used for the study of gout, cardiovascular disease or osteoarthritis.
For research use only. We do not sell to patients.
- Formula: C19H24N6
- Molecular Weight:336.43
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
|
NLRP3 |
IL-1β 6 nM (IC50) |
| Species | Dose | Route | CL | Vss | T1/2 | F |
|---|---|---|---|---|---|---|
| Dog[1] | 0.1 mg/kg | i.v. | 10 mL/min/kg | 6.3 L/kg | 9.4 h | / |
| Dog[1] | 0.3 mg/kg | p.o. | 10 mL/min/kg | 6.3 L/kg | 9.4 h | 75 % |
| Mice[1] | 1 mg/kg | i.v. | 27 mL/min/kg | 2.9 L/kg | 2.0 h | / |
| Mice[1] | 3 mg/kg | p.o. | 27 mL/min/kg | 2.9 L/kg | 2.0 h | 54 % |
| Rat[1] | 0.3 mg/kg | i.v. | 29 mL/min/kg | 6.9 L/kg | 3.9 h | / |
| Rat[1] | 3 mg/kg | p.o. | / | 6.9 L/kg | 29 mL/min/kg | 93 % |
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Female C57BL6/JRj mice (7-13 weeks) were challenged with LPS (2.5 mg/kg) for 2 h[1]
-
Dosage:0.3 mg/kg, 1 mg/kg, 3 mg/kg
-
Administration:Oral; 1 h prior to LPS; once
-
Result:Showed complete inhibition of IL-1β in the acute mouse peritonitis model when administered at 3 mg/kg p.o.
Lower doses of 1 and 0.3 mg/kg, resulted in 78 and 66% efficacy, respectively.
Chemical Information
-
Molecular Weight 336.43
-
Formula C19H24N6
-
SMILES
CC1=CC2=C(N1)N=C(C=C2)C3=C(C=C(N=N3)N[C@@H]4CCCN(C4)C)C
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)